ASMB Assembly Biosciences, Inc.

NASDAQ
$21.29

Assembly Biosciences, Inc. (ASMB) is expected to report earnings on February 11, 2027, after the market close. The consensus earnings estimate is $3.19 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +6.7% since its last earnings release on November 12, 2026.

Assembly Biosciences Missed Consensus Estimates
Thursday, November 12, 2026 · 4:00 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 11
Thursday · 4:00 PM ET
Earnings Whisper
-
vs $3.19
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $21.22

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Assembly Biosciences, Inc.

Assembly Biosciences Inc, formerly Ventrus Biosciences Inc, is a pharmaceutical company. The Company is engaged in the late-stage clinical development of gastrointestinal products in areas of unmet need, anal fissures, and fecal incontinence.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.